Concepts (218)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Caspase 6 | 14 | 2026 | 21 | 6.400 |
Why?
|
| Caspase 9 | 8 | 2021 | 21 | 3.310 |
Why?
|
| Zika Virus | 5 | 2025 | 37 | 3.120 |
Why?
|
| Viral Nonstructural Proteins | 6 | 2025 | 94 | 2.650 |
Why?
|
| Caspase 3 | 9 | 2021 | 108 | 2.530 |
Why?
|
| Caspases | 9 | 2021 | 176 | 2.490 |
Why?
|
| Caspase 7 | 8 | 2019 | 17 | 2.210 |
Why?
|
| Serine Endopeptidases | 4 | 2025 | 121 | 2.000 |
Why?
|
| Green Fluorescent Proteins | 7 | 2020 | 372 | 1.740 |
Why?
|
| Protease Inhibitors | 4 | 2025 | 106 | 1.730 |
Why?
|
| Apoptosis | 12 | 2021 | 1098 | 1.660 |
Why?
|
| Zika Virus Infection | 3 | 2025 | 38 | 1.560 |
Why?
|
| Models, Molecular | 20 | 2019 | 1162 | 1.460 |
Why?
|
| Neurodegenerative Diseases | 3 | 2026 | 152 | 1.390 |
Why?
|
| Protein Conformation | 15 | 2025 | 792 | 1.340 |
Why?
|
| Allosteric Site | 6 | 2014 | 31 | 1.330 |
Why?
|
| Fluorescent Dyes | 3 | 2025 | 202 | 1.320 |
Why?
|
| Mutation, Missense | 5 | 2018 | 190 | 1.250 |
Why?
|
| Proteolysis | 6 | 2018 | 154 | 1.220 |
Why?
|
| Zinc | 3 | 2018 | 95 | 1.210 |
Why?
|
| Protein Structure, Secondary | 10 | 2017 | 260 | 1.060 |
Why?
|
| Peptides | 4 | 2025 | 591 | 1.020 |
Why?
|
| Nuclear Magnetic Resonance, Biomolecular | 2 | 2025 | 85 | 0.990 |
Why?
|
| Flavivirus | 2 | 2024 | 8 | 0.980 |
Why?
|
| Dengue Virus | 3 | 2020 | 99 | 0.970 |
Why?
|
| Neoplasm Proteins | 2 | 2018 | 285 | 0.960 |
Why?
|
| Cysteine | 2 | 2018 | 108 | 0.940 |
Why?
|
| Cysteine Endopeptidases | 2 | 2025 | 95 | 0.920 |
Why?
|
| Caspase Inhibitors | 6 | 2026 | 24 | 0.910 |
Why?
|
| Chikungunya virus | 1 | 2025 | 3 | 0.890 |
Why?
|
| Fluorescence Resonance Energy Transfer | 2 | 2024 | 83 | 0.870 |
Why?
|
| Catalytic Domain | 9 | 2024 | 201 | 0.870 |
Why?
|
| Protein Binding | 12 | 2025 | 1640 | 0.860 |
Why?
|
| Protein Engineering | 4 | 2016 | 85 | 0.850 |
Why?
|
| Serine | 2 | 2016 | 90 | 0.840 |
Why?
|
| Enzyme Activation | 6 | 2026 | 391 | 0.780 |
Why?
|
| Peptide Hydrolases | 3 | 2024 | 79 | 0.780 |
Why?
|
| Molecular Probes | 2 | 2013 | 34 | 0.780 |
Why?
|
| Neoplasms | 3 | 2018 | 1368 | 0.760 |
Why?
|
| Allosteric Regulation | 7 | 2025 | 71 | 0.740 |
Why?
|
| Disulfides | 3 | 2018 | 67 | 0.700 |
Why?
|
| Crystallography, X-Ray | 8 | 2017 | 419 | 0.680 |
Why?
|
| Amino Acid Sequence | 11 | 2021 | 1589 | 0.660 |
Why?
|
| Binding Sites | 9 | 2019 | 921 | 0.630 |
Why?
|
| Humans | 39 | 2025 | 65140 | 0.630 |
Why?
|
| Drug Resistance, Neoplasm | 2 | 2018 | 217 | 0.610 |
Why?
|
| Amino Acid Substitution | 6 | 2018 | 238 | 0.610 |
Why?
|
| Molecular Dynamics Simulation | 2 | 2017 | 134 | 0.610 |
Why?
|
| Inflammation | 1 | 2026 | 1192 | 0.590 |
Why?
|
| Eukaryotic Initiation Factor-4G | 1 | 2018 | 5 | 0.570 |
Why?
|
| Protein Folding | 2 | 2018 | 268 | 0.570 |
Why?
|
| Autophagy-Related Proteins | 1 | 2018 | 15 | 0.560 |
Why?
|
| Genes, Reporter | 3 | 2020 | 257 | 0.560 |
Why?
|
| Directed Molecular Evolution | 2 | 2016 | 9 | 0.560 |
Why?
|
| Caspase Activation and Recruitment Domain | 1 | 2018 | 2 | 0.550 |
Why?
|
| Protein Multimerization | 3 | 2018 | 181 | 0.540 |
Why?
|
| Proto-Oncogene Proteins c-abl | 1 | 2017 | 6 | 0.540 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 1 | 2018 | 94 | 0.520 |
Why?
|
| p21-Activated Kinases | 1 | 2016 | 6 | 0.510 |
Why?
|
| Proteins | 6 | 2021 | 764 | 0.500 |
Why?
|
| Enzyme Assays | 2 | 2013 | 13 | 0.480 |
Why?
|
| Fluorescence | 2 | 2020 | 93 | 0.410 |
Why?
|
| Phosphorylation | 4 | 2018 | 962 | 0.400 |
Why?
|
| Substrate Specificity | 4 | 2025 | 341 | 0.380 |
Why?
|
| Kinetics | 6 | 2020 | 760 | 0.360 |
Why?
|
| Escherichia coli | 5 | 2021 | 714 | 0.360 |
Why?
|
| X-Linked Inhibitor of Apoptosis Protein | 1 | 2012 | 8 | 0.360 |
Why?
|
| Proline | 1 | 2012 | 46 | 0.360 |
Why?
|
| Protein Kinases | 1 | 2012 | 153 | 0.340 |
Why?
|
| Nanocapsules | 3 | 2017 | 21 | 0.340 |
Why?
|
| Antiviral Agents | 1 | 2013 | 321 | 0.330 |
Why?
|
| Repressor Proteins | 1 | 2012 | 351 | 0.310 |
Why?
|
| Peptide Library | 1 | 2009 | 33 | 0.300 |
Why?
|
| Enzyme Stability | 3 | 2017 | 47 | 0.290 |
Why?
|
| Molecular Sequence Data | 6 | 2015 | 1979 | 0.290 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2009 | 500 | 0.260 |
Why?
|
| Protein Domains | 2 | 2018 | 154 | 0.260 |
Why?
|
| Nanoparticles | 3 | 2021 | 544 | 0.260 |
Why?
|
| Protein Structure, Tertiary | 3 | 2013 | 676 | 0.250 |
Why?
|
| Nucleoside-Triphosphatase | 1 | 2025 | 40 | 0.230 |
Why?
|
| Recombinant Proteins | 3 | 2013 | 710 | 0.230 |
Why?
|
| Single Molecule Imaging | 1 | 2025 | 24 | 0.230 |
Why?
|
| Mutation | 5 | 2016 | 2661 | 0.220 |
Why?
|
| Chikungunya Fever | 1 | 2025 | 4 | 0.220 |
Why?
|
| RNA Stability | 1 | 2025 | 104 | 0.220 |
Why?
|
| DEAD-box RNA Helicases | 1 | 2025 | 131 | 0.220 |
Why?
|
| Sequence Analysis, Protein | 1 | 2004 | 31 | 0.220 |
Why?
|
| Cytosol | 2 | 2017 | 182 | 0.220 |
Why?
|
| Enzymes | 1 | 2004 | 35 | 0.210 |
Why?
|
| Protons | 2 | 2017 | 67 | 0.210 |
Why?
|
| Protein Structure, Quaternary | 1 | 2004 | 102 | 0.210 |
Why?
|
| Models, Chemical | 1 | 2004 | 137 | 0.210 |
Why?
|
| Catalysis | 3 | 2011 | 164 | 0.210 |
Why?
|
| Caspase 8 | 2 | 2021 | 66 | 0.200 |
Why?
|
| Drug Carriers | 2 | 2017 | 188 | 0.200 |
Why?
|
| Jurkat Cells | 3 | 2021 | 109 | 0.200 |
Why?
|
| Lipopolysaccharides | 1 | 2026 | 625 | 0.200 |
Why?
|
| Animals | 8 | 2026 | 21345 | 0.190 |
Why?
|
| RNA | 1 | 2025 | 426 | 0.180 |
Why?
|
| Endosomes | 2 | 2021 | 180 | 0.180 |
Why?
|
| Salmonella | 1 | 2021 | 45 | 0.170 |
Why?
|
| Pancreatic Polypeptide | 2 | 2012 | 10 | 0.170 |
Why?
|
| Chromatography, High Pressure Liquid | 2 | 2013 | 223 | 0.160 |
Why?
|
| Gels | 2 | 2017 | 77 | 0.160 |
Why?
|
| Protein Stability | 2 | 2012 | 96 | 0.160 |
Why?
|
| Flavivirus Infections | 1 | 2020 | 4 | 0.160 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2021 | 175 | 0.150 |
Why?
|
| RNA, Messenger | 1 | 2025 | 1574 | 0.150 |
Why?
|
| Enzyme Precursors | 1 | 2019 | 11 | 0.150 |
Why?
|
| Nanopores | 1 | 2019 | 14 | 0.150 |
Why?
|
| Models, Biological | 1 | 2004 | 1192 | 0.150 |
Why?
|
| Porins | 1 | 2019 | 63 | 0.150 |
Why?
|
| Dithionitrobenzoic Acid | 1 | 2018 | 4 | 0.150 |
Why?
|
| Pliability | 1 | 2018 | 6 | 0.150 |
Why?
|
| Serine Proteinase Inhibitors | 1 | 2018 | 10 | 0.140 |
Why?
|
| Sulfones | 1 | 2018 | 43 | 0.140 |
Why?
|
| Structure-Activity Relationship | 2 | 2013 | 355 | 0.140 |
Why?
|
| Mice, Inbred C57BL | 1 | 2026 | 3485 | 0.140 |
Why?
|
| Disease Models, Animal | 1 | 2026 | 2293 | 0.140 |
Why?
|
| Liver Neoplasms | 1 | 2021 | 308 | 0.140 |
Why?
|
| Bacterial Outer Membrane Proteins | 1 | 2019 | 127 | 0.140 |
Why?
|
| Mice | 3 | 2026 | 11119 | 0.140 |
Why?
|
| Hydrolysis | 1 | 2018 | 147 | 0.140 |
Why?
|
| Drug Delivery Systems | 1 | 2021 | 333 | 0.140 |
Why?
|
| Arginine | 1 | 2018 | 136 | 0.130 |
Why?
|
| Cell Line, Tumor | 2 | 2021 | 1565 | 0.130 |
Why?
|
| Phosphotransferases | 1 | 2017 | 22 | 0.130 |
Why?
|
| ErbB Receptors | 1 | 2018 | 127 | 0.130 |
Why?
|
| Deuterium Exchange Measurement | 1 | 2017 | 19 | 0.130 |
Why?
|
| Adenosine Triphosphate | 1 | 2019 | 301 | 0.130 |
Why?
|
| HeLa Cells | 4 | 2025 | 541 | 0.130 |
Why?
|
| Tyrosine | 1 | 2017 | 93 | 0.130 |
Why?
|
| Signal Transduction | 2 | 2021 | 3153 | 0.130 |
Why?
|
| Protein Conformation, alpha-Helical | 1 | 2017 | 22 | 0.130 |
Why?
|
| Proteomics | 1 | 2019 | 293 | 0.130 |
Why?
|
| Flow Cytometry | 2 | 2016 | 663 | 0.130 |
Why?
|
| Ligands | 3 | 2013 | 415 | 0.120 |
Why?
|
| Plasmids | 2 | 2021 | 294 | 0.120 |
Why?
|
| MCF-7 Cells | 1 | 2016 | 65 | 0.120 |
Why?
|
| Cell Proliferation | 2 | 2021 | 1038 | 0.120 |
Why?
|
| Escherichia coli Proteins | 1 | 2019 | 277 | 0.120 |
Why?
|
| Polymers | 2 | 2021 | 332 | 0.120 |
Why?
|
| Lamins | 1 | 2016 | 5 | 0.120 |
Why?
|
| Biological Products | 1 | 2017 | 93 | 0.120 |
Why?
|
| Oxidation-Reduction | 2 | 2017 | 326 | 0.110 |
Why?
|
| Lipids | 1 | 2017 | 328 | 0.110 |
Why?
|
| Proteome | 1 | 2016 | 152 | 0.110 |
Why?
|
| Lung Neoplasms | 1 | 2021 | 702 | 0.110 |
Why?
|
| Paclitaxel | 1 | 2015 | 102 | 0.110 |
Why?
|
| Microscopy, Fluorescence | 2 | 2017 | 401 | 0.110 |
Why?
|
| Cognitive Dysfunction | 1 | 2018 | 350 | 0.100 |
Why?
|
| Mutagenesis | 1 | 2014 | 133 | 0.100 |
Why?
|
| Molecular Docking Simulation | 1 | 2013 | 81 | 0.100 |
Why?
|
| Drug Discovery | 1 | 2014 | 96 | 0.100 |
Why?
|
| Circular Dichroism | 1 | 2013 | 108 | 0.090 |
Why?
|
| Molecular Weight | 1 | 2013 | 193 | 0.090 |
Why?
|
| Thrombin | 1 | 2012 | 21 | 0.090 |
Why?
|
| Peptide Mapping | 1 | 2012 | 29 | 0.090 |
Why?
|
| Spectrometry, Fluorescence | 1 | 2013 | 94 | 0.090 |
Why?
|
| Mutant Proteins | 1 | 2013 | 105 | 0.090 |
Why?
|
| Mass Spectrometry | 2 | 2015 | 295 | 0.090 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2014 | 268 | 0.090 |
Why?
|
| Molecular Mimicry | 1 | 2012 | 31 | 0.090 |
Why?
|
| Aminoisobutyric Acids | 1 | 2012 | 9 | 0.090 |
Why?
|
| Blotting, Western | 1 | 2013 | 611 | 0.090 |
Why?
|
| Protein Interaction Mapping | 1 | 2012 | 69 | 0.090 |
Why?
|
| Molecular Sequence Annotation | 1 | 2012 | 67 | 0.090 |
Why?
|
| Apoenzymes | 1 | 2011 | 4 | 0.090 |
Why?
|
| NIH 3T3 Cells | 1 | 2011 | 99 | 0.080 |
Why?
|
| Peptide Fragments | 1 | 2013 | 417 | 0.080 |
Why?
|
| Alzheimer Disease | 1 | 2018 | 765 | 0.080 |
Why?
|
| Protein Transport | 1 | 2012 | 405 | 0.080 |
Why?
|
| Molecular Structure | 2 | 2015 | 316 | 0.080 |
Why?
|
| Computational Biology | 1 | 2012 | 367 | 0.080 |
Why?
|
| Temperament | 1 | 2009 | 20 | 0.070 |
Why?
|
| Protein Denaturation | 1 | 2009 | 67 | 0.070 |
Why?
|
| Thioredoxins | 1 | 2009 | 17 | 0.070 |
Why?
|
| Isotope Labeling | 1 | 2009 | 69 | 0.070 |
Why?
|
| Sequence Alignment | 1 | 2009 | 300 | 0.070 |
Why?
|
| Cloning, Molecular | 1 | 2009 | 385 | 0.070 |
Why?
|
| Viral Proteins | 1 | 2009 | 270 | 0.060 |
Why?
|
| Cell Death | 2 | 2020 | 289 | 0.060 |
Why?
|
| Hydrophobic and Hydrophilic Interactions | 2 | 2017 | 281 | 0.060 |
Why?
|
| Endoplasmic Reticulum | 1 | 2025 | 177 | 0.050 |
Why?
|
| Dimerization | 1 | 2004 | 145 | 0.050 |
Why?
|
| Amides | 1 | 2004 | 60 | 0.050 |
Why?
|
| Enzyme Inhibitors | 1 | 2004 | 367 | 0.050 |
Why?
|
| Genetic Vectors | 1 | 2009 | 918 | 0.050 |
Why?
|
| Colorimetry | 1 | 2022 | 26 | 0.050 |
Why?
|
| Homeostasis | 1 | 2004 | 379 | 0.040 |
Why?
|
| Bacteriolysis | 1 | 2021 | 7 | 0.040 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2021 | 129 | 0.040 |
Why?
|
| Salmonella typhimurium | 1 | 2021 | 85 | 0.040 |
Why?
|
| Endocytosis | 1 | 2021 | 152 | 0.040 |
Why?
|
| Signal-To-Noise Ratio | 1 | 2020 | 61 | 0.040 |
Why?
|
| Dithiothreitol | 1 | 2017 | 18 | 0.030 |
Why?
|
| Polymerization | 1 | 2017 | 36 | 0.030 |
Why?
|
| Glutathione | 1 | 2017 | 55 | 0.030 |
Why?
|
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2017 | 89 | 0.030 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 1 | 2018 | 103 | 0.030 |
Why?
|
| Liposomes | 1 | 2017 | 116 | 0.030 |
Why?
|
| Drug Design | 1 | 2018 | 137 | 0.030 |
Why?
|
| Ultraviolet Rays | 1 | 2017 | 147 | 0.030 |
Why?
|
| Cryoelectron Microscopy | 1 | 2017 | 217 | 0.030 |
Why?
|
| Cell Line | 1 | 2020 | 2024 | 0.030 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2018 | 509 | 0.030 |
Why?
|
| Drug Synergism | 1 | 2015 | 142 | 0.030 |
Why?
|
| Molecular Conformation | 1 | 2015 | 115 | 0.030 |
Why?
|
| Drug Stability | 1 | 2015 | 144 | 0.030 |
Why?
|
| Emulsions | 1 | 2017 | 493 | 0.030 |
Why?
|
| Receptor, PAR-1 | 1 | 2012 | 5 | 0.020 |
Why?
|
| Quantum Theory | 1 | 2012 | 8 | 0.020 |
Why?
|
| Databases, Protein | 1 | 2012 | 45 | 0.020 |
Why?
|
| Cytoplasm | 1 | 2013 | 283 | 0.020 |
Why?
|
| Internet | 1 | 2012 | 467 | 0.020 |
Why?
|
| Algorithms | 1 | 2012 | 1050 | 0.020 |
Why?
|
| Male | 1 | 2021 | 31047 | 0.010 |
Why?
|
| Female | 1 | 2021 | 34018 | 0.010 |
Why?
|